Johnson & Johnson
NYSE: JNJ
$151.87
-$1.37 (-0.9%)
Closing Price on November 14, 2024
JNJ Articles
Jon OggThe markets may have topped and are acting choppy after Fed speak and after North Korean rhetoric, but U.S. investors can count on several big dividend hikes that we see as being almost...
Published:
Jon OggDividends and income growth drive value and income investors alike. Companies raising their dividends often keep investors far longer than companies that refuse to reward their shareholders by...
Published:
thinkstockThe venerable Dow Jones Industrial Average has been a benchmark for investors since its creation in 1896 by Charles Dow. Twelve stocks made up that first list, which was designed to...
Published:
Last Updated:
ThinkstockThe U.S. Food and Drug Administration (FDA) last night rejected an application from Johnson & Johnson (NYSE: JNJ) and Germany’s Bayer A.G. to extend the use of the two companies’...
Published:
Last Updated:
White House Photo by Pete SouzaBerkshire Hathaway Inc. (NYSE: BRK-A) has been actively watched in the news of late. After its participation in the $28 billion acquisition of H.J. Heinz Co. (NYSE:...
Published:
Last Updated:
White House Photo by Pete SouzaBerkshire Hathaway Inc. (NYSE: BRK-A) and Warren Buffett released their full stock holdings for 2013 on Thursday after the close. Earlier in the week we highlighted how...
Published:
Last Updated:
courtesy of the Walt Disney Co.No company has a better reputation among American consumers than Amazon.com. The online retailer pushed Apple out of the the top slot this year, according to a recent...
Published:
Last Updated:
White House Photo by Pete SouzaBerkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett may have surprised the markets with the $28 billion purchase of H.J. Heinz Company (NYSE: HNZ), but...
Published:
Last Updated:
ThinkstockS&P 500 dividend growth continues to outpace earnings growth, a trend that likely will continue for a few more years. Low yields on fixed income alternatives and historically low...
Published:
Last Updated:
ThinkstockHave some widely owned health care names hit a wall when it comes to growth and earnings? In a research report issued today, Credit Suisse Group Inc. (NYSE: CS) issues some not very...
Published:
Last Updated:
Jon OggThese are some of this Thursday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. AbbVie Inc. (NYSE: ABBV) started as Neutral at Credit Suisse. Akamai...
Published:
ThinkstockBoston Scientific Corp. (NYSE: BSX) is trading higher today after earnings and after a restructuring direction has been set. Unfortunately for its investors, Boston Scientific remains a...
Published:
courtesy of AOL, IncThe Federal Aviation Administration faces criticism about approving a Boeing Co. (NYSE: BA) battery that caused safety concerns about the 787. (Reuters) Google Inc. (NASDAQ:...
Published:
U.S. equity markets opened about flat this morning following the holiday weekend in the U.S. Foreign markets were also more or less mixed. In Europe, the German and eurozone economic indexes came in...
Published:
Last Updated:
U.S. equity markets opened mixed this morning, with the Nasdaq Composite lower on a weak quarterly earnings report last night from Intel Corp. (NASDAQ: INTC). The big news for today came out of...
Published:
Last Updated: